Funding for this research was provided by:
National Institutes of Health (RO1 CA210637, RO1CA206444, and RO1 CA183459, UO1 CA200466, P50 CA127297 and PO1 CA217798)
Text and Data Mining valid from 2018-12-01
Received: 28 August 2018
Accepted: 14 November 2018
First Online: 19 December 2018
Ethics approval and consent to participate
: Not applicable
: All authors read and approved the final manuscript.
: SKB is one of the co-founders of Sanguine Diagnostics and Therapeutics, Inc. WMJ is Chief Scientific Officer of Sanguine Diagnostics and Therapeutics, Inc. Other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.